1.Adak, GK, Long, SM, O'Brien, SJ. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 2002; 51: 832–841.
2.Mead, PS, et al. Food-related illness and death in the United States. Emerging Infectious Diseasess 1999; 5: 607–625.
3.Centers for Disease Control. Q fever among slaughterhouse workers – California. Morbidity and Mortality Weekly Report 1986; 35: 223–2264.
4.Thomas, DR, et al. Zoonotic illness – determining risks and measuring effects – association between current animal exposure and a history of illness in a well characterised rural population in the UK. Journal of Epidemiology and Community Health 1994; 48: 151–155.
5.Whitney, EAS, et al. Seroepidemiologic and cccupational risk survey for Coxiella burnetii antibodies among US veterinarians. Clinical Infectious Diseases 2009; 48: 550–557.
6.Silvestro, L, et al. Asymptomatic carriage of Verocytotoxin-producing Escherichia coli O157 in farm workers in Northern Italy. Epidemiology & Infection 2004; 132: 915–919.
7.Gladstone, BP, et al. Polymerase chain reaction in the detection of an ‘outbreak’ of asymptomatic viral infections in a community birth cohort in south India. Epidemiology & Infection 2008; 136: 399–405.
8.Wilson, JB, et al. Vero cytotoxigenic Escherichia coli infection in dairy farm families. Infectious Disease 1996; 174: 1021–1027.
9.Evans, J, et al. Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England. European Journal of Epidemiology 2000; 16: 885–889.
10.Reymond, D, et al. Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. Journal of Clinical Microbiology 1996; 34: 2053–2057.
11.Belongia, EA, et al. Diarrhea incidence and farm-related risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children. Journal of Infectious Diseases 2003; 187: 1460–1468.
12.Park, J, et al. Prevalence of Shiga toxin-encoding genes and risk factors among dairy farmers in Gyeonggi Province, Korea. Scandinavian Journal of Infectious Diseases 2012; 43: 275–279.
13.Quilliam, RS, et al. Seroprevalence and risk factors associated with Escherichia coli O157 in a farming population. Zoonoses and Public Health 2012; 59: 83–88.
14.Jones, DM, Robinson, DA. Occupational exposure to Campylobacter jejuni infection. Lancet 1981; 1: 440–441.
15.Price, LB, et al. Neurologic symptoms and neuropathologic antibodies in poultry workers exposed to Campylobacter jejuni. Journal of Occupational & Environmental Medicine 2007; 49: 748–755.
16.Ellis, A, et al. Outbreak of Campylobacter infection among farm workers: an occupational hazard. Canadian Communicable Disease Report 1995; 21: 153–156.
17.Wilson, IG. Airborne Campylobacter infection in a poultry worker: case report and review of the literature. Communicable Disease & Public Health 2004; 7: 349–353.
18.Cawthraw, SA, et al. Antibodies, directed towards Campylobacter jejuni antigens, in sera from poultry abattoir workers. Clinical & Experimental Immunology 2000; 122: 55–60.
19.Kapperud, G, et al. Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway. American Journal of Epidemiology 2003; 158: 234–242.
20.Studahl, A, Andersson, Y. Risk factors for indigenous Campylobacter infection: a Swedish case-control study. Epidemiology & Infection 2000; 125: 269–275.
21.Eberhart-Phillips, J, et al. Campylobacteriosis in New Zealand: results of a case-control study. Journal of Epidemiology & Community Health 1997; 51: 686–691.
22.Adak, GK, et al. The public health laboratory service national case-control study of primary indigenous sporadic cases of Campylobacter infection. Epidemiology & Infection 1995; 115: 15–22.
23.Robinson, DA, Jones, DM. Milk-borne Campylobacter infection. British Medical Journal 1981; 282: 1374–1376.
24.Blaser, MJ, Sazie, E, Williams, LP. The influence of immunity on raw milk-associated Campylobacter infection. Journal of the American Medical Association 1987; 257: 43–46.
25.Goh, S, et al. Sporadic cryptosporidiosis, North Cumbria, England, 1996–2000. Emerging Infectious Diseases 2004; 10: 1007–1015.
26.Hunter, PR, et al. Sporadic cryptosporidiosis case-control study with genotyping. Emerging Infectious Diseases 2004; 10: 1241–1249.
27.Pollock, KGJ, et al. Spatial and temporal epidemiology of sporadic human cryptosporidiosis in Scotland. Zoonoses and Public Health 2009; 57: 487–492.
28.Chalmers, RM, et al. Epidemiology of anthroponotic and zoonotic humancryptosporidiosis in England and Wales, 2004–2006. Epidemiology & Infection 2011; 139: 700–712.
29.Casemore, DP. The antibody response to cryptosporidium: development of a serological test and its use in a study of immunologically normal persons. Journal of Infection 1987; 14: 125–134.
30.Garcia-Rodriguez, JA, et al. The seroepidemiology of Cryptosporidium species in different population groups in Spain. Serodiagnosis & Immunotherapy in Infectious Disease 1989; 3: 367–373.
31.Lengerich, EJ, et al. Increased exposure to Cryptosporidia among dairy farmers in Wisconsin. Journal of Infectious Diseases 1993; 167: 1252–1255.
32.Gait, R, et al. Outbreak of cryptosporidiosis among veterinary students. Veterinary Record 2008; 162: 843–845.
33.Chalmers, RM, Davies, A. Minireview: clinical cryptosporidiosis. Experimental Parasitology 2010; 124: 138–146.
34.Swift, L, Hunter, PR. What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean? European Journal of Epidemiology 2004; 19: 219–223.
35.Frost, FJ, et al. How clean must our drinking water be: the importance of protective immunity. Journal of Infectious Diseases 2005; 191: 809–814.
36.Okhuysen, PC, et al. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infection and Immunity 1998; 66: 441–443.
37.Chappell, CL, et al. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. American Journal of Tropical Medicine & Hygiene 1999; 60: 157–164.
38.Fone, DL, Barker, RM. Associations between human and animal infections with Salmonella Typhimurium DT104 in Herefordshire. Communicable Disease Reports. CDR Review 1994; 4: R136–R140.
39.Baker, MG, et al. A recurring salmonellosis epidemic in New Zealand linked to contact with sheep. Epidemiology & Infection 2007; 135: 76–83.
40.Cherry, B, et al. Salmonella Typhimurium outbreak associated with veterinary clinic. Emerging Infectious Diseases 2004; 10: 2249–2251.
41.Wright, JG, et al. Multidrug-resistant Salmonella Typhimurium in four animal facilities. Emerging Infectious Diseases 2005; 11: 1235–1241.
42.Wright, JG, et al. Infection control practices and zoonotic disease risks among veterinarians in the United States. Journal of the American Medical Association 2008; 232: 1863–1872.
43.Shlim, DR, et al. Persistent high risk of diarrhea among foreigners in Nepal during the first 2 years of residence. Clinical Infectious Diseases 1999; 29: 613–616.
44.Wenneras, C, Erling, VA. Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world. Journal of Health & Population Nutrition 2004; 22: 370–382.
45.Havelaar, AH, et al. Immunity to Campylobacter: its role in risk assessment and epidemiology. Critical Reviews in Microbiology 2009; 35: 1–22.
46.Hoge, CW, et al. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. Journal of the American Medical Association 1996; 275: 533–538.
47.Hong, S, et al. Anti-Shiga toxin immunoglobulin G antibodies in healthy South Korean slaughterhouse workers. Scandinavian Journal of Infectious Diseases 2012; 44: 168–173.
48.Hellard, ME, et al. Prevalence of enteric pathogens among community based asymptomatic individuals. Journal of Gastroenterology & Hepatology 2000; 15: 290–293.
49.Haffejee, IE, Windsor, I, Moosa, A. Asymptomatic rotavirus infections among normal Indian children in Chatsworth, Durban. South African Medical Journal 1989; 76: 599–601.
50.Morrow, AL, et al. Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. Journal of Pediatrics 2004; 145: 297–303.
51.Tikare, NV, Mantur, BG, Bidari, LH. Brucellar meningitis in an infant – evidence for human breast milk transmission. Journal of Tropical Pediatrics 2008; 54: 272–274.
52.Celebi, G, et al. Asymptomatic Brucella bacteraemia and isolation of Brucella melitensis biovar 3 from human breast milk. Scandinavian Journal of Infectious Diseases 2007; 39: 205–208.
53.Clemens, J, et al. Sociodemographic, hygienic and nutritional correlates of Helicobacter pylori infection of young Bangladeshi children. Pediatric Infectious Disease Journal 1996; 15: 1113–1118.
54.Alikhani, MY, et al. Prevalence of enteropathogenic and Shiga toxin-producing Escherichia coli among children with and without diarrhoea in Iran. Journal of Health & Population Nutrition 2007; 25: 88–93.
55.Lindesmith, L, et al. Human susceptibility and resistance to Norwalk virus infection. Nature Medicine 2003; 9: 548–553.
56.Burgner, D, Jamieson, SE, Blackwell, JM. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infectious Diseases 2006; 6: 653–663.
57.Ottenhoff, T, et al. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nature Genetics 2002; 32: 97–105.
58.Janssen, R, et al. Host-pathogen interactions in Campylobacter infections: the host perspective. Clinical Microbiology Review 2008; 21: 505–518.
59.Hawker, JI, et al. A large outbreak of Q fever in the West Midlands: windborne spread into a metropolitan area? Communicable Disease & Public Health 1998; 1: 180–187.
60.Everhart, JE, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. Journal of Infectious Diseases 2000; 181: 1359–1363.
61.Horowitz, MA, et al. Large outbreak of foodborne Salmonellosis on Navajo Nation Indian Reservation, epidemiology and secondary transmission. American Journal of Public Health 1977; 67: 1071–1076.
62.Palmer, SR, Rowe, B. Comminicable diseases – investigation of outbreaks of Salmonella in hospitals. British Medical Journal 1983; 287: 891–893.
63.Parry, SM, Salmon, RL. Sporadic STEC O157 infection: secondary household transmission in Wales. Emerging Infectious Diseases 1998; 4: 657–661.
64.Pennington, H. The Public Inquiry into the September 2005 Outbreak of E. coli O157 in South Wales. London: The Stationery Office, HMSO, 2009.
65.Cowden, J. Campylobacter – epidemiologic paradoxes. British Medical Journal 1992; 305: 132–133.
66.Evans, MR, et al. A milk-borne Campylobacter outbreak following an educational farm visit. Epidemiology & Infection 1996; 117: 457–462.
67.Defra. Zoonoses Report 2009 UK. Department for the Environment, Food and Rural Affairs, London, 2009.
68.David, ST, et al. Petting zoo-associated Escherichia coli O157:H7 – secondary transmission, asymptomatic infection, and prolonged shedding in the classroom. Canadian Communicable Disease Report 2004; 30: 173–80.
69.Working Group of the former PHLS Advisory Committee on Gastrointestinal Infections. Preventing person-to-person spread following gastrointestinal infections: guidelines for public health physicians and environmental health officers. Communicable Disease & Public Health 2004; 7: 362–384.
70.Subcommittee of the PHLS Advisory Committee on Gastrointestinal Infections. Guidelines for the control of infection with verocytotoxin producing Eschericia coli (VTEC). Communicable Disease & Public Health 2000; 3: 14–23.
71.Al-Jader, L, et al. Outbreak of Escherichia coli O157 in a nursery: lessons for prevention. Archives of Disease in Childhood 1999; 81: 60–63.
72.Werber, D, et al. Preventing household transmission of Shiga toxin producing Escherichia coli O157 infection: Promptly separating siblings might be the key. Clinical & Infectious Diseases 2008; 46: 1189–1196.
73.Albrich, WC, Harbarth, S. Health-care workers: source, vector, or victim of MRSA? Lancet Infectious Diseases 2008; 8: 289–301.
74.Voss, A, et al. Methicillin-resistant Staphylococcus aureus in pig farming. Emerging Infectious Diseases 2005; 11: 1965–1966.
75.Wulf, MWH, et al. Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clinical Microbiology & Infection 2008; 14: 29–34.
76.Huber, H, et al. Prevalence and characteristics of methicillin-resistant Staphylococcus aureus in humans in contact with farm animals, in livestock, and in food of animal origin, Switzerland, 2009. Eurosurveillance 2010; 15: 19542
77.Meier, PA, et al. A prolonged outbreak of methicillin resistant Staphylococcus aureus in the burn unit of a tertiary medical center. Infection Control & Hospital Epidemiology 1996; 17: 798–802.
78.Blok, H, et al. Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital. Infection Control & Hospital Epidemiology 2003; 24: 679–685.
79.Saiman, L, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infection Control & Hospital Epidemiology 2003; 24: 317–321.
80.Bertin, ML, et al. Outbreak of methicillin-mesistant Staphylococcus aureus colonization and infection in a neonatal intensive care unit epidemiologically linked to a healthcare worker with chronic otitis. Infection Control & Hospital Epidemiology 2006; 27: 581–585.
81.Grundmann, H, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet 2006; 368: 874–885.
82.Garcia-Graells, C, et al. Livestock veterinarians at high risk of acquiring methicillin-resistant Staphylococcus aureus ST398. Epidemiology & Infection 2012; 140: 383–389.
83.Cookson, B, et al. Meticillin-resistant Staphylococcus aureus (MRSA): screening and decolonisation. International Journal of Antimicrobial Agents 2011; 37: 195–201.
84.Catry, B, et al. Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health. Epidemiology & Infection 2010; 138: 626–644.
85.Cross, P, Rigby, D, Edwards-Jones, G. Eliciting expert opinion on the effectiveness and practicality of interventions in the farm and rural environment to reduce human exposure to Escherichia coli O157. Epidemiology & Infection 2012; 40: 643–654.